Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.340.360.360.340.34

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.34 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.34
Mar20240.36
Mar20230.36
Mar20220.34
Mar20210.34

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.34
-5.56
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34
0.00
Mar2021 0.34 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,529.3 Cr 3.7% 10.5% 30.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,982.0 Cr -0.7% -0.5% -3.1% Stock Analytics
DIVIS LABORATORIES ₹172,878.0 Cr 2.8% 2.2% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,095.0 Cr 1.5% 3.4% 12.4% Stock Analytics
CIPLA ₹122,175.0 Cr 0.8% 0.1% 3.1% Stock Analytics
DR REDDYS LABORATORIES ₹107,154.0 Cr 0.4% 3.2% 0.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

10.5%

30.6%

SENSEX

0.4%

-0.1%

6.1%


You may also like the below Video Courses